Open original FDA record ↗Recall record
- FDA identifier
- Z-1723-2014
- Company in FDA record
- Medtronic Neuromodulation
- FDA classification date
- Jun 4, 2014
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Medtronic has determined that an Ascenda catheter kit may have had endotoxin in excess of USP limits.
Source facts
- Action
- There was only one consignee affected by the recall. The consignee was contacted by phone on 5/2/14 and the information was provided verbally. General Manager & Vice President, Pain Stimulation/Targeted Drug Delivery spoke via phone with the physician managing the patient. The following information was provided: "Medtronic identified the potential for endotoxin levels exceeding USP requirements on product recently implanted (Model 8780, serial number N457062003). "There may be the potential for serious patient injury due to endotoxin within the first hours after implant. "Medtronic recommends observing the patient for symptoms of meningitis. Also to be aware that CSF would not test with a positive culture because endotoxin induced meningitis results in an aseptic meningitis. The physician expressed confidence in the management of the patient and stated he was calling the nursing care facility to increase monitoring of the patient. Subsequent information was received regarding the patient indicating there were no signs of an endotoxin reaction.
- Initiated
- 2014-05-02
- Root cause
- Release of Material/Component prior to receiving test results
- Terminated
- 2014-10-07
- Distribution
- Distributed in the state of CT.
- Recall number
- Z-1723-2014
- Recall status
- Terminated
- CDRH record ID
- 127290
- FDA classified
- 2014-06-04
- Recall event number
- 68295